REGENXBIO Inc. (NASDAQ:RGNX) is held by 168 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 5,782,808 | 25,997 | 0.45% | $48,459,930.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,756,811 | -614,082 | -9.64% | $82,898,078.00 |
| Redmile Group, LLC | 31 Mar, 2026 | 4,368,804 | -324,585 | -6.92% | $62,910,778.00 |
| Redmile Group, LLC | 31 Mar, 2026 | 4,368,804 | 0 | 0.00% | $36,610,578.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,570,874 | 1,718,660 | 92.79% | $51,420,586.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 3,553,502 | -4,520,994 | -55.99% | $51,170,429.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 3,483,800 | -69,702 | -1.96% | $27,069,126.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 3,374,140 | 36,042 | 1.08% | $48,587,616.00 |
| State Street Corp | 31 Mar, 2026 | 2,731,485 | 444,749 | 19.45% | $22,889,844.00 |
| State Street Corp | 31 Mar, 2026 | 2,286,736 | 301,858 | 15.21% | $32,928,998.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,066,157 | 51,369 | 2.55% | $17,314,400.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,014,788 | 310,520 | 18.22% | $29,012,955.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,007,146 | 2,007,146 | 0.00% | $16,819,883.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,839,463 | -1,731,411 | -48.49% | $15,414,700.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 1,500,000 | 300,000 | 25.00% | $12,570,000.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,361,962 | 72,307 | 5.61% | $19,612,253.00 |
| Qube Research & Technologies Ltd | 31 Mar, 2026 | 1,310,493 | 867,803 | 196.03% | $10,981,931.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 1,200,000 | 100,000 | 9.09% | $17,280,000.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 1,160,380 | 454,977 | 64.50% | $16,709,472.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,145,206 | 19,658 | 1.75% | $16,495,225.00 |